Lifeng Luo

发表

Neutralizing Monoclonal Antibody, mAb 10D8, Is an Effective Detoxicant against Abrin-a Both In Vitro and In Vivo

Hua Xu, Zhi Li, Lei Guo, 2022, Toxins.

Activation of NALP1 inflammasomes in rats with adjuvant arthritis; a novel therapeutic target of carboxyamidotriazole in a model of rheumatoid arthritis

Wei Chen, Lei Zhu, Juan Li, 2015, British journal of pharmacology.

Double Amplification upon Immuno-Gold Nanoparticles Promoted Trace Measurement of Ricin by Biolayer Interferometry

Xinying Li, Hua Xu, Zhi Li, 2022, Sensors and Actuators B: Chemical.

Carboxyamidotriazole Ameliorates Experimental Colitis by Inhibition of Cytokine Production, Nuclear Factor-κB Activation, and Colonic Fibrosis

Rui Ju, Lei Zhu, De-chang Zhang, 2012, Journal of Pharmacology and Experimental Therapeutics.

Applications and Prospects of Oligonucleotide Aptamers in Mass Spectrometry

Lei Guo, Jianwei Xie, Lifeng Luo, 2020 .

An Aptameric Biolayer Interferometric Assay for Detection of Recombinant Human Erythropoietin-α

Lei Guo, Jianwei Xie, Lifeng Luo, 2020 .

Label-free differentiation and quantification of ricin, abrin from their agglutinin biotoxins by surface plasmon resonance.

Weijun Kang, Hua Xu, Zhi Li, 2021, Talanta.

Highly sensitive MALDI-MS measurement of active ricin: insight from more potential deoxynucleobase-hybrid oligonucleotide substrates.

Bin Xu, Zhi Li, Lei Guo, 2021, The Analyst.

Carboxyamidotriazole: a novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases.

Rui Ju, Lei Zhu, Juan Li, 2015, European journal of pharmacology.